Detalhe da pesquisa
1.
Cost-effectiveness of insulin degludec versus insulin glargine U100 in adults with type 1 and type 2 diabetes mellitus in Bulgaria.
BMC Endocr Disord
; 19(1): 132, 2019 Dec 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31796048
2.
[The evaluation of cost-effectiveness and cost-utility of valganciclovir for the prophylaxis of cytomegalovirus disease to 200 days after kidney transplantation]. / Ocena kosztowej efektywnosci i kosztowej uzytecznosci stosowania walgancyklowiru w profilaktyce wystapienia choroby cytomegalowirusowej do 200. dnia od przeszczepu nerki.
Pol Merkur Lekarski
; 34(204): 332-8, 2013 Jun.
Artigo
Polonês
| MEDLINE | ID: mdl-23882930
3.
Stereoselective and catalytic access to ß-enaminones: an entry to pyrimidines.
J Org Chem
; 77(20): 9205-20, 2012 Oct 19.
Artigo
Inglês
| MEDLINE | ID: mdl-23006434
4.
Treating Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in the Czech Republic: Cost-Effectiveness of IDegLira Versus iGlarLixi.
Diabetes Ther
; 10(2): 493-508, 2019 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-30706364
5.
Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes: A Long-Term Cost-Effectiveness Analysis in Estonia.
Diabetes Ther
; 10(1): 159-176, 2019 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-30535837
6.
The Management of Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide: A Long-Term Cost-Effectiveness Analysis in Slovakia.
Adv Ther
; 36(8): 2034-2051, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31168765
7.
Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U100 in Patients with Type 1 and Type 2 Diabetes Mellitus in Serbia.
Diabetes Ther
; 9(3): 1201-1216, 2018 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-29700772